MYD88 and neoplasm: Global deletion of type I IFN receptor (IFNAR) or MyD88 (an adaptor molecule that operates downstream of IL-1 receptor and Toll-like receptors) also diminished tumor resistance conferred by Gc-/- FT (Fig. 2D and Supplementary Fig. 3B).